Alector, Inc. (ALEC) vs RxSight, Inc. (RXST)
A side-by-side comparison of Alector, Inc. and RxSight, Inc. across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of October 6, 2026. Differences are shown without an overall score or investment verdict.
ALEC
Alector, Inc.
$1.81HealthcareDelayed quote: Oct 6, 2026, 4:00 PM EDT
RXST
RxSight, Inc.
$4.65HealthcareDelayed quote: Oct 6, 2026, 4:00 PM EDT
Total return — ALEC vs RXST
growth of $100 · dividends reinvested · last 5yALEC -91.7% (-39.2%/yr)RXST -70.3% (-21.5%/yr)RXST compounded faster over this window
ALEC RXST
ALEC vs RXST: by the numbers
- •ALEC is the larger company ($201M vs $192M market cap).
- •Both run net losses; RXST's is the smaller (-36.80% vs -850.13% net margin).
- •RXST grew revenue faster over the past five years (48.85% vs -8.35% CAGR).
Metrics side by side
Valuation
| Metric | ALEC | RXST |
|---|---|---|
| P/S ratio | 14.50 | 1.51 |
| P/B ratio | N/A | 0.73 |
Profitability
| Metric | ALEC | RXST |
|---|---|---|
| Gross margin | 54.09% | 77.50% |
| Operating margin | -692.83% | -43.20% |
| Net margin | -850.13% | -36.80% |
| ROE | N/A | -17.83% |
| ROIC | -71.04% | -20.24% |
Growth (annualized)
| Metric | ALEC | RXST |
|---|---|---|
| Revenue CAGR (5Y) | -8.35% | 48.85% |
| Total return CAGR (5Y) | -39.17% | -19.19% |
Frequently asked
- Which has grown faster, ALEC or RXST?
- Over the past five years, RXST grew revenue faster — ALEC at a -8.35% CAGR versus RXST at 48.85%.
- How have ALEC and RXST total returns compared?
- Over the past 5 years, ALEC delivered -39.17% and RXST delivered -19.19% annualized total return. Past performance doesn't predict future results.
Go deeper
Dig into the metrics
Alector ROERxSight ROEAlector operating marginRxSight operating marginAlector revenue growthRxSight revenue growthAlector free cash flowRxSight free cash flow
Alector & RxSight appear in these rankings
Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified October 6, 2026.